Literature DB >> 23597143

FCGR2A and FCGR3A polymorphisms in classical Hodgkin lymphoma by Epstein-Barr virus status.

Hervé Ghesquières1, Ahmet Dogan, Brian K Link, Matthew J Maurer, Julie M Cunningham, Anne J Novak, Beth R Larrabee, Susan L Slager, Cristine Allmer, Thomas M Habermann, Stephen M Ansell, James R Cerhan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23597143      PMCID： PMC3999590          DOI： 10.3109/10428194.2013.796048

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  14 in total

1.  Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

Authors:  Pierre Bruhns; Bruno Iannascoli; Patrick England; David A Mancardi; Nadine Fernandez; Sylvie Jorieux; Marc Daëron
Journal:  Blood       Date:  2008-11-18       Impact factor: 22.113

2.  Correlation of Fc-γ RIIA polymorphisms with latent Epstein-Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas.

Authors:  Panagiotis T Diamantopoulos; Vassiliki Kalotychou; Katerina Polonyfi; Maria Sofotasiou; Amalia Anastasopoulou; Athanassios Galanopoulos; Nikolaos Spanakis; Theodoros Vassilakopoulos; Maria Angelopoulou; Maria Siakantaris; Eleni Variami; Christos Poziopoulos; Evangelos Terpos; Panagoula Kollia; Nora-Athina Viniou
Journal:  Leuk Lymphoma       Date:  2013-01-23

3.  Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma.

Authors:  Lynn I Levin; Ellen T Chang; Richard F Ambinder; Evelyne T Lennette; Mark V Rubertone; Risa B Mann; Michael Borowitz; Edward G Weir; Susan L Abbondanzo; Nancy E Mueller
Journal:  Blood       Date:  2012-09-12       Impact factor: 22.113

4.  Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection.

Authors:  W Henle; G Henle; J Andersson; I Ernberg; G Klein; C A Horwitz; G Marklund; L Rymo; C Wellinder; S E Straus
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

5.  Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.

Authors:  Jennifer A Kanakry; Hailun Li; Lan L Gellert; M Victor Lemas; Wen-son Hsieh; Fangxin Hong; King L Tan; Randy D Gascoyne; Leo I Gordon; Richard I Fisher; Nancy L Bartlett; Patrick Stiff; Bruce D Cheson; Ranjana Advani; Thomas P Miller; Brad S Kahl; Sandra J Horning; Richard F Ambinder
Journal:  Blood       Date:  2013-02-05       Impact factor: 22.113

Review 6.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

7.  FcgammaRIIa genotype predicts progression of HIV infection.

Authors:  Donald N Forthal; Gary Landucci; Jay Bream; Lisa P Jacobson; Tran B Phan; Benjamin Montoya
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

Review 8.  FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy.

Authors:  N M van Sorge; W-L van der Pol; J G J van de Winkel
Journal:  Tissue Antigens       Date:  2003-03

9.  HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.

Authors:  Karen A McAulay; Craig D Higgins; Karen F Macsween; Annette Lake; Ruth F Jarrett; Faye L Robertson; Hilary Williams; Dorothy H Crawford
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

10.  Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

Authors:  Henrik Hjalgrim; Johan Askling; Klaus Rostgaard; Stephen Hamilton-Dutoit; Morten Frisch; Jin-Song Zhang; Mette Madsen; Nils Rosdahl; Helle Bossen Konradsen; Hans H Storm; Mads Melbye
Journal:  N Engl J Med       Date:  2003-10-02       Impact factor: 91.245
View more
  5 in total

Review 1.  Candidate gene association studies and risk of Hodgkin lymphoma: a systematic review and meta-analysis.

Authors:  Amit Sud; Kari Hemminki; Richard S Houlston
Journal:  Hematol Oncol       Date:  2015-06-05       Impact factor: 5.271

2.  Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma.

Authors:  Louise Soo Yee Tan; Benjamin Wong; Nagaraja Rao Gangodu; Andrea Zhe Ern Lee; Anthony Kian Fong Liou; Kwok Seng Loh; Hao Li; Ming Yann Lim; Andres M Salazar; Chwee Ming Lim
Journal:  Oncoimmunology       Date:  2018-08-27       Impact factor: 8.110

Review 3.  Host genetics of Epstein-Barr virus infection, latency and disease.

Authors:  Charlotte J Houldcroft; Paul Kellam
Journal:  Rev Med Virol       Date:  2014-11-27       Impact factor: 6.989

4.  Host genetic variants and gene expression patterns associated with Epstein-Barr virus copy number in lymphoblastoid cell lines.

Authors:  Charlotte J Houldcroft; Velislava Petrova; Jimmy Z Liu; Dan Frampton; Carl A Anderson; Astrid Gall; Paul Kellam
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

Review 5.  Fcγ Receptors in Solid Organ Transplantation.

Authors:  Tomas Castro-Dopico; Menna R Clatworthy
Journal:  Curr Transplant Rep       Date:  2016-10-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.